An open-label, phase I/II trial of gemtuzumab ozogamicin in combination with zosuquidar in patients with CD33 positive acute myeloid leukemia
Phase of Trial: Phase I/II
Latest Information Update: 12 Mar 2008
At a glance
- Drugs Gemtuzumab ozogamicin; Zosuquidar
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 12 Mar 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Aug 2006 Status change
- 02 Nov 2005 New trial record.